Tolerability of a New 10% Liquid Immunoglobulin for Intravenous Use, Privigen®, at Different Infusion Rates

By Sleasman John   Duff Carla   Dunaway Theresa   Rojavin Mikhail   Stein Mark  

Journal of Clinical Immunology, Vol. 30, Iss. 3, 2010-05 ,pp. : 442-448

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam^® 10%) in patients with immune thrombocytopenia

By Robak Tadeusz   Mainau Claudia   Pyringer Barbara   Chojnowski Krzysztof   Warzocha Krzysztof   Dmoszynska Anna   Straub Jan   Imbach Paul  

Hematology, Vol. 15, Iss. 5, 2010-10 ,pp. : 351-359

Maney Publishing

Access to resources Recommend Favorite

Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

By Krasovec S.   Ornani A.   Oleastro M.   Rosenzweig S.   Roy A.   Perez L.   Campos G.   MarÍn N.   Martinez A.   Mahieu C.   Manfredi M.   Sisti A.   Zelazko M.  

Journal of Clinical Immunology, Vol. 27, Iss. 2, 2007-03 ,pp. : 227-232

Springer Publishing Company

Access to resources Recommend Favorite

The response to intravenous immunoglobulin replacement therapy in patients with asthma with specific antibody deficiency

By Schwartz Howard J.   Hostoffer Robert W.   McFadden E. Regis   Berger Melvin  

Allergy and Asthma Proceedings, Vol. 27, Iss. 1, 2006-01 ,pp. : 53-58

OceanSide Publications, Inc

Access to resources Recommend Favorite

Efficacy and safety of Privigen^®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura

By Robak T.   Salama A.   Kovaleva L.   Vyhovska Y.   Davies S. V.   Mazzucconi M. G.   Zenker O.   Kiessling P.    

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 227-236

Maney Publishing

Access to resources Recommend Favorite